Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide

Yasuhide Motoyoshi, Kazuhisa Kaminoda, Ohki Saitoh, +5

Oncology Reports

Association Between Liver Fibrosis and Insulin Sensitivity in Chronic Hepatitis C Patients

Naota Taura, Tatsuki Ichikawa, Keisuke Hamasaki, +12

The American Journal of Gastroenterology

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

Masakuni Tateyama, Hiroshi Yatsuhashi, Naota Taura, +12

Journal of Gastroenterology

HepatologyHepatitis CHepatitis C VirusViral HepatitisLiver Physiology +7

Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis

Mariko Kusaba, Kazuhiko Nakao, Takashi Goto, +8

Journal of Hepatology

Signal TransductionSignaling PathwayCell RegulationMedicineLiver Physiology +8

Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings

Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi, +15

Cancers

Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection

Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, +12

Internal Medicine

DHMEQ, a novel NF-kB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells

Daisuke Nishimura, Hiroki Ishikawa, Kojiro Matsumoto, +11

International Journal of Oncology

Chemoprevention StrategyNovel Nf-kb InhibitorApoptosisImmunologyCell Death +18

Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: Long-term trends in Japan

Naota Taura, Keisuke Hamasaki, Kazuhiko Nakao, +12

Oncology Reports

Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals

Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, +14

Hepatology Research

Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease

Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, +12

Biomedical Reports